China’s share of the global drug development pipeline grew from 3% in 2013 to 28% in 2023, positioning China as the second-largest region for clinical trials after the United States. Additionally, the ...
As the deadline approaches for President Donald Trump’s reciprocal tariffs, economists at Morgan Stanley found it will be ...
US President Donald Trump said it would be possible to reach a fresh trade deal with China, signaling he is open to heading ...
Stockhead on MSN22h
Bumper results day sees RIO, FMG, PLS and more reportRio Tinto saw profits lift, but Fortescue copped a big hit on lower iron ore prices, while lithium miners reported ... Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback